Inovio Pharma (INO) Tops Q1 EPS by 31c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $0.77 --0%
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue from affiliated entity: 574.6K
Today's EPS Names:
NSLR, OCTV, ACB, More
EPS Growth %: +60.7%
Financial Fact:
License fee and milestone revenue from affiliated entity: 574.6K
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q1 EPS of $0.16, $0.31 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $110 thousand versus the consensus estimate of $300 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
- Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
